| Brooke Anne Ochoa, OT | |
|
3640 Mundy Mill Rd Ste 102b, Gainesville, GA 30504-8226 | |
| (770) 287-8821 | |
| (770) 287-8797 |
| Full Name | Brooke Anne Ochoa |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 6 Years |
| Location | 3640 Mundy Mill Rd Ste 102b, Gainesville, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124583620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT007269 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Independent Physical Therapy Of Georgia Llc | 2961312244 | 430 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's NurOwn™ autologous adult stem cell product candidate for the treatment of amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.
NeuroVigil, Inc. is setting to collaborate with a number of partners in the Silicon Valley where it is opening a satellite research laboratory at NASA Research Park in Mountain View, CA, to develop assistive technologies for individuals suffering from ALS and other conditions affecting the central nervous system.
Risk factor modification efforts could help reduce the chance of another heart attack and death among the more than 15 million Americans with coronary heart disease. Yet some patients-especially women and minorities-leave the hospital with poorly managed risk factors.
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis. To do this, however, they primarily have to rely on visual inspection and palpation - an enormous challenge especially in the case of small tumor nests or remaining tumor borders after the primary tumor excision.
› Verified 8 days ago
| Provider Name | Independent Physical Therapy Of Georgia Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780636068 PECOS PAC ID: 2961312244 Enrollment ID: O20040303000396 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's NurOwn™ autologous adult stem cell product candidate for the treatment of amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.
NeuroVigil, Inc. is setting to collaborate with a number of partners in the Silicon Valley where it is opening a satellite research laboratory at NASA Research Park in Mountain View, CA, to develop assistive technologies for individuals suffering from ALS and other conditions affecting the central nervous system.
Risk factor modification efforts could help reduce the chance of another heart attack and death among the more than 15 million Americans with coronary heart disease. Yet some patients-especially women and minorities-leave the hospital with poorly managed risk factors.
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis. To do this, however, they primarily have to rely on visual inspection and palpation - an enormous challenge especially in the case of small tumor nests or remaining tumor borders after the primary tumor excision.
› Verified 8 days ago
| Provider Name | Benchmark Physical Therapy, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1083666903 PECOS PAC ID: 1557395209 Enrollment ID: O20050921001120 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's NurOwn™ autologous adult stem cell product candidate for the treatment of amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.
NeuroVigil, Inc. is setting to collaborate with a number of partners in the Silicon Valley where it is opening a satellite research laboratory at NASA Research Park in Mountain View, CA, to develop assistive technologies for individuals suffering from ALS and other conditions affecting the central nervous system.
Risk factor modification efforts could help reduce the chance of another heart attack and death among the more than 15 million Americans with coronary heart disease. Yet some patients-especially women and minorities-leave the hospital with poorly managed risk factors.
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis. To do this, however, they primarily have to rely on visual inspection and palpation - an enormous challenge especially in the case of small tumor nests or remaining tumor borders after the primary tumor excision.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brooke Anne Ochoa, OT 6397 Lee Hwy Ste 300, Chattanooga, TN 37421-4915 Ph: (423) 238-7217 | Brooke Anne Ochoa, OT 3640 Mundy Mill Rd Ste 102b, Gainesville, GA 30504-8226 Ph: (770) 287-8821 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's NurOwn™ autologous adult stem cell product candidate for the treatment of amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.
NeuroVigil, Inc. is setting to collaborate with a number of partners in the Silicon Valley where it is opening a satellite research laboratory at NASA Research Park in Mountain View, CA, to develop assistive technologies for individuals suffering from ALS and other conditions affecting the central nervous system.
Risk factor modification efforts could help reduce the chance of another heart attack and death among the more than 15 million Americans with coronary heart disease. Yet some patients-especially women and minorities-leave the hospital with poorly managed risk factors.
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis. To do this, however, they primarily have to rely on visual inspection and palpation - an enormous challenge especially in the case of small tumor nests or remaining tumor borders after the primary tumor excision.
› Verified 8 days ago
Krisi April Probert, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 655 Jesse Jewell Pkwy Se, Suite C, Gainesville, GA 30501 Phone: 770-539-9001 Fax: 770-539-9217 | |
Tina Marie Black, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4502 Summer Gate Ct, Gainesville, GA 30506 Phone: 770-378-5986 Fax: 770-536-0346 | |
Christa Perry Tullis, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Spring St, Suite B, Gainesville, GA 30501 Phone: 770-532-5721 Fax: 770-532-5929 | |
Shannon Randall, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2030 Windward Ln, Gainesville, GA 30501 Phone: 770-535-8181 | |
Brianna Lynn Brown, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 428 S Enota Dr Ne, Gainesville, GA 30501 Phone: 678-865-4947 | |
Mr. Myron Westley Green, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 955 Interstate Ridge Dr Unit E, Gainesville, GA 30501 Phone: 678-936-8695 | |
Anna Weatherford, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7985 Knight Rd, Gainesville, GA 30506 Phone: 770-781-4899 |